Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 8.42
(3.69%)
CNY 8.42
(3.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.62 Billion CNY | 23.85% |
| 2022 | 2.12 Billion CNY | 87.31% |
| 2021 | 1.13 Billion CNY | -11.8% |
| 2020 | 1.28 Billion CNY | -22.05% |
| 2019 | 1.64 Billion CNY | -0.85% |
| 2018 | 1.66 Billion CNY | 100.73% |
| 2017 | 827.33 Million CNY | 8.47% |
| 2016 | 762.75 Million CNY | 2.01% |
| 2015 | 747.69 Million CNY | 43.8% |
| 2014 | 519.95 Million CNY | 17.27% |
| 2013 | 443.38 Million CNY | 46.18% |
| 2012 | 303.31 Million CNY | 24.17% |
| 2011 | 244.27 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 1.98 Billion CNY | -30.19% |
| 2024 Q1 | 2.63 Billion CNY | 0.24% |
| 2024 Q2 | 1.77 Billion CNY | -32.42% |
| 2023 FY | 2.62 Billion CNY | 23.85% |
| 2023 Q2 | 2.38 Billion CNY | 6.82% |
| 2023 Q3 | 2.41 Billion CNY | 0.88% |
| 2023 Q4 | 2.62 Billion CNY | 8.97% |
| 2023 Q1 | 2.23 Billion CNY | 5.48% |
| 2022 Q1 | 1.33 Billion CNY | 18.07% |
| 2022 Q2 | 1.84 Billion CNY | 38.15% |
| 2022 Q4 | 2.12 Billion CNY | 5.08% |
| 2022 Q3 | 2.01 Billion CNY | 9.28% |
| 2022 FY | 2.12 Billion CNY | 87.31% |
| 2021 FY | 1.13 Billion CNY | -11.8% |
| 2021 Q1 | 1.42 Billion CNY | 10.67% |
| 2021 Q2 | 1.34 Billion CNY | -5.16% |
| 2021 Q3 | 1.33 Billion CNY | -0.54% |
| 2021 Q4 | 1.13 Billion CNY | -15.5% |
| 2020 Q1 | 1.72 Billion CNY | 4.79% |
| 2020 FY | 1.28 Billion CNY | -22.05% |
| 2020 Q2 | 1.72 Billion CNY | -0.11% |
| 2020 Q4 | 1.28 Billion CNY | 3.39% |
| 2020 Q3 | 1.24 Billion CNY | -27.98% |
| 2019 Q2 | 1.63 Billion CNY | -2.69% |
| 2019 Q1 | 1.68 Billion CNY | 1.47% |
| 2019 FY | 1.64 Billion CNY | -0.85% |
| 2019 Q4 | 1.64 Billion CNY | -2.51% |
| 2019 Q3 | 1.68 Billion CNY | 2.99% |
| 2018 Q1 | 923.29 Million CNY | 11.6% |
| 2018 FY | 1.66 Billion CNY | 100.73% |
| 2018 Q4 | 1.66 Billion CNY | 98.13% |
| 2018 Q3 | 838.16 Million CNY | -3.75% |
| 2018 Q2 | 870.83 Million CNY | -5.68% |
| 2017 FY | 827.33 Million CNY | 8.47% |
| 2017 Q1 | 808.4 Million CNY | 5.98% |
| 2017 Q2 | 894.93 Million CNY | 10.7% |
| 2017 Q3 | 887.55 Million CNY | -0.82% |
| 2017 Q4 | 827.33 Million CNY | -6.78% |
| 2016 Q3 | 737.02 Million CNY | 8.85% |
| 2016 Q1 | 481.6 Million CNY | -35.59% |
| 2016 Q2 | 677.08 Million CNY | 40.59% |
| 2016 Q4 | 762.75 Million CNY | 3.49% |
| 2016 FY | 762.75 Million CNY | 2.01% |
| 2015 Q1 | 49.06 Million CNY | -88.85% |
| 2015 FY | 747.69 Million CNY | 43.8% |
| 2015 Q3 | 712.16 Million CNY | 0.0% |
| 2015 Q4 | 747.69 Million CNY | 4.99% |
| 2014 Q4 | 439.95 Million CNY | 0.0% |
| 2014 FY | 519.95 Million CNY | 17.27% |
| 2013 FY | 443.38 Million CNY | 46.18% |
| 2012 FY | 303.31 Million CNY | 24.17% |
| 2011 FY | 244.27 Million CNY | 0.0% |